Activity value 72china Supplier,Last transaction date:
2026-06-29
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for yichang sanxia xinmei pharmaceutical co from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 17 transactions, with a transaction quantity of 53970 and a transaction weight of 0.
YearTransactionsQuantityWeight
202515352280
202617539700
Bill of lading data
<
1/15
>
Trade date
2026/06/29
B/L No.
108383295530
Suppliers
yichang sanxia xinmei pharmaceutical co
Buyers
công ty cổ phần thành nhơn
Product description
Nguyên liệu sản xuất thuốc thú y: DOXYCYCLINE HYCLATE. NSX: Kunshan Chemical & Pharmaceutical Co., Ltd. Mã CAS: 24390-14-5. Hàng mới 100%
Expand
Trade date
2026/06/16
B/L No.
108344635561
Suppliers
yichang sanxia xinmei pharmaceutical co
Buyers
công ty cổ phần dược và vật tư thú y
Product description
Nguyên liệu sản xuất thuốc thú y: DOXYCYCLINE HYCLATE. NSX: Kunshan Chemical & Pharmaceutical Co., Ltd. Mã CAS: 24390-14-5. Hàng mới 100%
Expand
Trade date
2026/06/12
B/L No.
108331962910
Suppliers
yichang sanxia xinmei pharmaceutical co
Buyers
công ty cổ phần uv
Product description
Nguyên liệu kháng sinh sản xuất thuốc thú y: DOXYCYCLINE HYCLATE. HSD: 02/2030. Đóng: 25KG/Drum. Mới: 100%. NSX: KUNSHAN CHEMICAL & PHARMACEUTICAL CO.,LTD - CHINA
Expand
Trade date
2026/04/16
B/L No.
108158680120
Suppliers
yichang sanxia xinmei pharmaceutical co
Buyers
công ty cổ phần thành nhơn
Product description
Nguyên liệu sản xuất thuốc thú y:OXYTETRACYCLINE HYDROCHLORIDE.Lot:26030300,26030310,26030320 sx:03/26, hsd:02/30, nsx:Yancheng dafeng Area tiansheng joint pharmaceutical.( Mục 6 - GP 0537/26/TY-QLT)
Expand
Trade date
2026/04/01
B/L No.
108110146210
Suppliers
yichang sanxia xinmei pharmaceutical co
Buyers
công ty cổ phần thành nhơn
yichang sanxia xinmei pharmaceutical co is china Supplier,
and primarily engages in the import and export business of products such as ceftriaxone sodium,entercavir,neomycin sulphate.
According to the 52wmb.com global trade database, as of 2026-06-29, the company has completed 61 international trades,
with its main trading regions covering vietnam,bangladesh,indonesia etc.
The core products include HS29419000,HS29411019,HS29413000 etc,
often transported via shanghai cn,port shanghai etc,
and its main trading partners are công ty cổ phần thành nhơn,công ty tnhh ruby,công ty tnhh thương mại quốc tế vhl.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on yichang sanxia xinmei pharmaceutical co is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.